Proteome Sciences (LON:PRM) Issues Quarterly Earnings Results

Proteome Sciences (LON:PRM) issued its earnings results on Thursday. The company reported GBX (1.15) (($0.02)) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.

Proteome Sciences Trading Up 12.3 %

LON:PRM opened at GBX 3.38 ($0.04) on Friday. The firm has a market capitalization of £9.98 million, a PE ratio of -2.45 and a beta of 0.07. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37. Proteome Sciences has a 12 month low of GBX 2.22 ($0.03) and a 12 month high of GBX 5.40 ($0.07). The business’s 50-day moving average is GBX 4.05 and its two-hundred day moving average is GBX 3.46.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.